Benefits
Better Bioavailability vs Fish Oil (Phospholipid Form)
EPA and DHA in krill oil are bound to phospholipids rather than to the triglycerides found in fish oil. The absorption reference on this page is a double-blind randomized crossover trial in 24 healthy volunteers, 600 mg of n-3 PUFA per treatment, 4 weeks per phase with an 8-week washout. Krill oil raised the omega-3 index in plasma and red blood cells more than fish oil did. The omega-3 index is a blood biomarker of omega-3 status, not a health outcome, and whether that difference allows a lower effective dose was not tested.
Improved GI Tolerability
Uncited on this page. None of the references here compared reflux, aftertaste or digestive symptoms between krill oil and fish oil. Better tolerability is a widely reported user impression, not a finding from the evidence cited.
Triglyceride Reduction
Uncited on this page. The lipid results described here come from a trial card with no reference attached, so none of them can be checked against a source. Of the studies cited here, the 4-week absorption trial found no change in serum triglycerides or HDL cholesterol, while total and LDL cholesterol rose with both krill and fish oil compared with a placebo oil; the 6-month knee trial at 4 g/day found no difference from placebo in serum lipids.
Astaxanthin Co-Delivery
Krill oil naturally contains astaxanthin, the red carotenoid that gives krill their color, and it helps protect the oil from oxidation. No reference on this page measured astaxanthin content, antioxidant status, or any skin or eye outcome. Astaxanthin content varies by product, and the figures commonly quoted for it are not verified by anything cited here.
Knee pain with joint swelling: no improvement in the largest trial
In the largest trial, 262 people with knee osteoarthritis, significant knee pain and joint swelling on MRI took 2 g/day of krill oil or placebo for 24 weeks. Knee pain fell by about 20 points on a 100-point scale in both groups, with no difference between them. The trial was government-funded, with capsules supplied by a krill oil maker.
Menstrual Comfort (Not Supported by the Evidence Cited Here)
No such trial appears among the references on this page, and nothing cited here measured menstrual symptoms. The prostaglandin explanation is a proposed mechanism rather than a result from any study listed here.
Knee joint comfort and stiffness: modest gains in two of three trials
Three placebo-controlled trials tested krill oil in adults with knee pain. A 6-month trial of 4 g/day in 235 adults with mild to moderate knee osteoarthritis and a 30-day trial of 2 g/day in 50 adults with mild knee pain found less pain and stiffness than placebo; both were industry-funded and the 6-month gains were small. The largest trial, 2 g/day for 24 weeks in 262 people, found no pain benefit.
Mechanism of action
Phospholipid vs Triglyceride EPA/DHA
In krill oil, EPA and DHA are esterified to phospholipid backbone (mostly phosphatidylcholine) — vs triglyceride backbone in fish oil. Phospholipid-bound omega-3s are absorbed via different pathway — better pancreatic lipase digestion, formation of mixed micelles, possibly direct lymphatic uptake. Result: higher omega-3 index per gram of EPA/DHA consumed.
Astaxanthin Antioxidant Activity
Astaxanthin (the red carotenoid that gives krill/salmon their color) is commonly described as having stronger antioxidant activity than other carotenoids, and it is active in both lipid and water phases. It protects krill oil from oxidation. No study cited on this page measured antioxidant status or any health effect of astaxanthin in people.
Choline Co-Delivery
Phosphatidylcholine in krill oil provides ~14% choline by weight — modest choline supplementation alongside omega-3s.
Same Underlying Omega-3 Mechanisms
Once absorbed, EPA and DHA from krill oil have same fundamental mechanisms as from fish oil — eicosanoid modulation, membrane composition, etc.
Clinical trials
Reported as a trial of krill oil (1-3 g/day) versus fish oil versus placebo in 120 people with high blood lipids over 90 days. Uncited: no reference on this page supports this card, so the design, the participant count, the duration and the results below cannot be traced to a source. The people described were also a clinical population with diagnosed high blood lipids rather than general users.
Reported as 120 people with high blood lipids. Uncited, so the number cannot be verified.
Reported as lower total cholesterol, LDL and triglycerides and higher HDL. No reference is attached to this card, so none of those results can be verified, and nothing here establishes krill oil as an effective lipid intervention. Industry-sponsored study (limitation).
Double-blind randomized crossover trial comparing krill oil with fish oil at 600 mg of n-3 PUFA per treatment, 4 weeks per phase with an 8-week washout, measuring the omega-3 index in plasma and red blood cells.
24 healthy volunteers.
Krill oil produced a greater rise in the omega-3 index, measured in plasma and red blood cells, than fish oil. The omega-3 index is a blood biomarker of omega-3 status. Serum triglycerides and HDL did not change, total and LDL cholesterol rose with both krill and fish oil compared with control, no clinical outcome was measured, and 24 healthy volunteers over 4 weeks is a small, short comparison.